Reporting an adverse event

Cycle is committed to protecting the safety of patients who receive our products.

Adverse events

Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable.

If you have experienced an adverse event or think you may be experiencing an adverse event, you should seek advice from a healthcare professional.

An adverse event is the development of an undesirable medical condition or the deterioration of a pre-existing medical condition following or during exposure to a pharmaceutical product, whether or not considered causally related to the product. An undesirable medical condition can be symptoms (e.g. nausea, chest pain), signs (e.g. tachycardia, enlarged liver) or the abnormal results of an investigation (e.g., laboratory findings, electrocardiogram).

All adverse events should be reported to Cycle Pharmaceuticals by:

TASCENSO ODT (fingolimod)

+1-888-533-1625 (toll-free USA and Canada)


All other products

+1-855-831-5413 (toll-free USA and Canada)